End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,631 KRW | +5.84% | +5.16% | -43.76% |
Business Summary
Number of employees: 363
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
72.1
%
| 64,743 | 99.3 % | 62,954 | 72.1 % | -2.76% |
Bio
19.3
%
| 274 | 0.4 % | 16,870 | 19.3 % | +6,047.42% |
Insulation
7.3
%
| - | - | 6,369 | 7.3 % | - |
Other
0.9
%
| - | - | 812 | 0.9 % | - |
Game
0.4
%
| 173 | 0.3 % | 358 | 0.4 % | +106.48% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 65,190 | 100.0 % | 87,364 | 100.0 % | +34.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jung-Chool Kim
CEO | Chief Executive Officer | 68 | 31/03/12 |
Yun-Gyeong Bae
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Jong-Su Gang
BRD | Director/Board Member | 60 | - |
Sung-Ho Kang
SAM | Sales & Marketing | 58 | - |
Min-Cheol Jeong
AUD | Comptroller/Controller/Auditor | 67 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jung-Chool Kim
CEO | Chief Executive Officer | 68 | 31/03/12 |
Jong-Su Gang
BRD | Director/Board Member | 60 | - |
Yun-Gyeong Bae
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Dong-chul Shin
BRD | Director/Board Member | 63 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,575,469 | 62,168,781 ( 93.38 %) | 822,388 ( 1.235 %) | 93.38 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
AP HEALTHCARE INC. 42.00% | 47,945,206 | 42.00% | 22,116,165 $ |
APROGEN BIOLOGICS INC. 1.24% | 8,223,876 | 1.24% | 1,166,475 $ |
APROGEN MEDICINES INC. -.--% | 0 | -.--% | 0 $ |
Company contact information
Aprogen Biologics, Inc.
Room 301 Gangho Building 6 Ogeum-ro 19-gil
06735, Seoul
+
http://www.aprogen-pharm.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-43.76% | 74.21M | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- A003060 Stock
- Company Aprogen Biologics Inc.